UBS Group »

Mersana Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $356k 153k 2.32
2023-09-30 $73k 57k 1.27
2023-06-30 $571k 174k 3.29
2023-03-31 $762k 185k 4.11
2022-12-31 $1.7M 289k 5.86
2022-09-30 $184k 26k 7.00
2022-06-30 $41k 8.8k 4.60
2022-03-31 $61k 15k 4.00
2021-12-31 $1.1M 181k 6.00
2021-09-30 $832k 88k 9.43
2021-06-30 $317k 23k 13.52
2021-03-31 $1.4M 87k 16.18
2020-12-31 $168k 6.4k 26.39
2020-09-30 $55k 3.0k 18.47
2020-06-30 $62k 2.7k 23.23
2020-03-31 $146k 25k 5.81
2019-12-31 $273k 46k 6.00
2019-09-30 $45k 29k 1.56
2019-06-30 $30k 7.5k 4.00
2019-03-31 $8.9k 1.5k 5.89
2018-12-31 $29k 7.3k 4.00
2018-09-30 $33k 3.3k 10.00
2018-06-30 $33k 1.8k 17.90
2018-03-31 $26k 1.6k 15.94
2017-12-31 $21k 1.3k 16.33
2017-09-30 $28k 1.6k 17.33
2017-06-30 $24k 1.7k 14.24